medigraphic.com
ISSN 1028-4796 (Impreso)

2016, Número 3

<< Anterior Siguiente >>

Rev Cubana Plant Med 2016; 21 (3)


Composición lipídica y evaluación de las actividades antioxidante y leishmanicida del basidiomiceto Ganoderma sp.

Pérez CCA, Santafé PGG, Torres TMG, Torres AOL, Montaño CMC, Robledo RVSM

Idioma: Español
Referencias bibliográficas: 58
Paginas: 318-331
Archivo PDF: 176.07 Kb.


RESUMEN

Introducción: los hongos del género Ganoderma han sido utilizados para el cuidado de la salud en la medicina tradicional asiática por más de 2000 años. Desde 1980 los estudios químicos han reportado un sin número de metabolitos secundarios con propiedades bioactivas.
Objetivo: identificar compuestos lipídicos en el extracto etanólico del hongo Ganoderma sp., además de evaluar sus actividades antioxidante y leishmanicida.
Métodos: la extracción de las fracciones lipídicas presentes en el cuerpo fructífero de Ganoderma sp. Se realizó por Cromatografía en Columna. La elucidación estructural se determinó por Espectrometría de Masas y Resonancia Magnética Nuclear. La actividad antioxidante del extracto etanólico fue evaluada con las metodologías del radical 2,2-difenil-1-picrilhidrazil (DPPH) y el radical catiónico 2,2'-azinobis (3-etilbenzotiazolina-6-ácido sulfónico) (ABTS); la actividad leishmanicida por citometría de flujo y la actividad citotóxica usando el ensayo colorimétrico de bromuro de 3-(4,5-dimetil-tiazol-2-il)-2,5-difenil tetrazolio (MTT) sobre la línea celular U937.
Resultados: diecinueve esteres metílicos y ergosterol fueron identificados por espectrometría de masas en el extracto etanólico. Un compuesto triterpenoidal se elucidó usando Espectroscopia de Resonancia Magnética Nuclear. Los valores de concentración media inhibitoria (IC50) de la actividad antioxidante del extracto etanólico para las metodologías de los radicales DPPH y ABTS fueron de 85,63 µg/mL y 62,82 µg/mL, respectivamente. Los valores de las actividades citotóxica y leishmanicida fueron › 200,0 µg/mL y 21,5 µg/mL ± 4,4 respectivamente.
Conclusiones: las estructuras de los derivados de ácidos grasos elucidados corresponden a compuestos con diferentes grados de insaturación. En este estudio se realizó el reporte de la Ganoderona A, como compuesto triterpenoidal. La elevada actividad antioxidante en relación a otros trabajos sugiere que este organismo es una fuente importante de metabolitos secundarios con propiedades captadoras de radicales libres, aunque los valores de actividad leishmanicida no fueron significativos se recomienda continuar con el estudio de otras particiones del extracto etanólico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bishop KS, Kao CH, Xu Y, Paterson RR, Glucina MP, Ferguson LR. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry. 2015;114:56-65.

  2. Cilerdžić J , Vukojević J, Stajić M, Stanojković T, Glamočlija J. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate. J Ethnopharmacology. 2014;155(1):312-319

  3. Sabulal B, Anil JJ, Balaji G. Secondary metabolites from Ganoderma. Phytochemistry. 2015;114:66-101.

  4. Tran HB , Yamamoto A, Matsumoto S, Ito H, Igami K, Miyazaki T, et al. Hypotensive Effects and Angiotensin-Converting Enzyme Inhibitory Peptides of Reishi (Ganoderma lingzhi) Auto-Digested Extract. Molecules. 2014;19(9):13473-13485.

  5. Nguyen VT, Tung NT, Cuong TD, Hung TM, Kim JA, Woo MH, et al. Cytotoxic and anti-angiogenic effects of lanostane triterpenoids from Ganoderma lucidum. Phytochem Lett. 2015;12:69-74.

  6. Liu Z, Xing J, Zheng S, Bo R, Luo L, Huang Y, et al. Ganoderma lucidum polysaccharides encapsulated in liposome as an adjuvant to promote Th1-bias immune response. Carbohydr Polym. 2016;142:141-48.

  7. Huang J, Nie Q, Liu X, Zhang S, Nie S, Huang D, et al. Ganoderma atrum polysaccharide modulates TNF-α secretion and mRNA expression in macrophages of S-180 tumor-bearing mice. Food Hydrocollo. 2016;53:24-30.

  8. Liu Z, Xing J, Huang Y, Bo R, Zheng S, Luo L, et al. Activation effect of Ganoderma lucidum polysaccharides liposomes on murine peritoneal macrophages. Int J Biol Macromol. 2016;82:973-78.

  9. Pi CC, Chu CL, Lu CY, Zhuang YJ, Wang CL, Yu YH, et al. Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo. Vaccine. 2014;32(3):401-08.

  10. Liu Z, Ma X, Deng B, Huang Y, Bo R, Gao Z, et al. Development of liposomal Ganoderma lucidum polysaccharide: Formulation optimization and evaluation of its immunological activity. Carbohydr Polym. 2015;117:510-17.

  11. Ma JQ, Liu CM, Qin ZH, Jiang JH, Sun YZ. Ganoderma applanatum terpenes protect mouse liver against benzo(α)pyren-induced oxidative stress and inflammation. Environ Toxicol Pharmacol. 2011;31(3):460-68.

  12. Liu YJ, Du JL, Cao LP, Jia R, Shen YJ, Zhao CY, et al. Anti-inflammatory and hepatoprotective effects of Ganoderma lucidum polysaccharides on carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio L.) . Int Immunopharmacol. 2015;25(1):112-20.

  13. Liu LY, Chen H, Liu C, Wang HQ, Kang J, Li Y, et al. Triterpenoids of Ganoderma theaecolum and their hepatoprotective activities. Fitoterapia. 2014;98:254-59.

  14. Peng XR, Liu JQ, Han ZH, Yuan XX, Luo HR, Qiu MH. Protective effects of triterpenoids from Ganoderma resinaceum on H2O2-induced toxicity in HepG2 cells. Food Chem. 2013;141(2):920-26.

  15. Chien RC, Yen MT, Tseng YH, Mau JL. Chemical characteristics and antiproliferation activities of Ganoderma tsugae polysaccharides. Carbohydr Polym. 2015;128:90-8.

  16. Ferreira I, Heleno SA, Reis FS, Stojkovic D, Queiroz MJ, Vasconcelos MH, Sokovic M. Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry. 2014;114:38-55.

  17. Zhang S, Nie S, Huang D, Huang J, Feng Y, Xie M. Ganoderma atrum polysaccharide evokes antitumor activity via cAMP-PKA mediated apoptotic pathway and downregulation of Ca2+/PKC signal pathway. Food Chem Toxicol. 2014;68:239-46.

  18. Wang JH, Zhou YJ, Zhang M, Kan L, He P. Active lipids of Ganoderma lucidum spores-induced apoptosis in human leukemia THP-1 cells via MAPK and PI3K pathways. J Ethnopharmacol. 2012;139(2):582-89.

  19. Zhu K, Nie S, Gong D, Xie M. Effect of polysaccharide from Ganoderma atrum on the serum metabolites of type 2 diabetic rats. Food Hydrocoll. 2016;53:31-36.

  20. Qiu J, Wang X, Song C. Neuroprotective and antioxidant lanostanoid triterpenes from the fruiting bodies of Ganoderma atrum. Fitoterapia. 2016;109:75-79.

  21. Huang Y, Li N, Wan JB, Zhang D, Yan D. Structural characterization and antioxidant activity of a novel heteropolysaccharide from the submerged fermentation mycelia of Ganoderma capense. Carbohydr Polym. 2015;134:752-60.

  22. Li K, Yu M, Hu Y, Guangming Ren, Tingting Zang, Xiuhong Xu, Juanjuan Qu. Three kinds of Ganoderma lucidum polysaccharides attenuate DDC-induced chronic pancreatitis in mice. Chem Biol Interact. 2016;247:30-38.

  23. Choi S, Nguyen VT, Tae N, Lee S, Sungwoo Ryoo, Byung-Sun Min, Jeong-Hyung Lee. Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW264.7 cells . Toxicol Appl Pharmacol. 2014;280(3):434-42.

  24. Hasnat MA, Pervin M, Cha KM, Kim SK, Lim BO. Anti-inflammatory activity on mice of extract of Ganoderma lucidum grown on rice via modulation of MAPK and NF- κB pathways. Phytochemistry. 2015;114:125-36.

  25. Zhang W, Tao J, Yang X, Yang Z, Zhang L, Liu H, Wu K, Wu J. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem Biophys Res Commun. 2014;449(3):307-12.

  26. Ma K, Li L, Bao L, He L, Sun C, Zhou B, Si S, Liu H. Six new 3,4-seco-27- norlanostane triterpenes from the medicinal mushroom Ganoderma boninense and their antiplasmodial activity and agonistic activity to LXR. Tetrahedron. 2015;71(12):1808-14.

  27. Ma K, Ren J, Han J, Bao L, Li L, Yao Y, Sun C, Zhou B, Liu H. Ganoboninketals AC, Antiplasmodial 3,4-seco-27-Norlanostane Triterpenes from Ganoderma boninense. J Nat Prod. 2014;77(8):1847-52.

  28. Isaka M, Chinthanom P, Sappan M, Danwisetkanjana K, Boonpratuang T, Choeyklin.R. Antitubercular Lanostane Triterpenes from Cultures of the Basidiomycete Ganoderma sp. BCC 16642. Jo Nat Prod. 2016;79(1):161-69.

  29. Gokce EC, Kahveci R, Atanur OM, Gürer B, Aksoy N, Gokce A, Sargon MF, Cemil B, Erdogan B, Kahvec O. Neuroprotective effects of Ganoderma lucidum polysaccharides against traumatic spinal cord injury in rats. Injury. 2015;46(11):2146-55.

  30. Ma HT, Hsieh JF, Chen ST. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 2015;114:109-13.

  31. Benito-Román O, Alonso E, Cocero MJ, Goto M. β-Glucan recovery from Ganoderma lucidum by means of pressurized hot water and supercritical CO2. Food and Bioproducts Processing. 2016;98:21-28.

  32. Lin KW, Maitraie D, Huang AM, Wang JP, Lin CN. Triterpenoids and an alkamide from Ganoderma tsugae. Fitoterapia. 2016;108:73-80.

  33. Dai WF, Guo PX, Tu ZC, Li RT, Cheng YX. Five new compounds from the fungus Ganoderma petchii. Fitoterapia. 2015;106:68-71.

  34. Peng XR, Liu JQ, Xia JJ, Wang CF, Li XY, Deng YY, Bao NM, Zhang ZR, Qiu MH. Lanostane triterpenoids from Ganoderma hainanense J. D. Zhao. Phytochemistry. 2015;(114):137-45.

  35. Zhao ZZ, Chen HP, Li ZH, Dong ZJ, Bai X, Zhou ZY, Feng T, Liu JK. Leucocontextins A-R, lanostane-type triterpenoids from Ganoderma leucocontextum. Fitoterapia. 2016;109:91-98.

  36. Lindequist U, Jülich WD, Witt S. Ganoderma pfeifferi - A European relative of Ganoderma lucidum. Phytochemistry. 2015;114:102-08

  37. Hu LL, Ma QY, Huang SZ, Guo ZK, Ma HX, Guo JC, Dai HF, Zhao YX. A new nortriterpenoid from the fruiting bodies of Ganoderma tropicum. Phytochem Lett. 2014;7:11-13.

  38. Zhao XR, Huo XK, Dong PP, Wang C, Huang SS, Zhang BJ, Zhang HL, Deng S, Liu KX, Ma XC, Inhibitory Effects of Highly Oxygenated Lanostane Derivatives from the Fungus Ganoderma lucidum on P-Glycoprotein and-Glucosidase. J Nat Prod. 2015;78(8):1868-76.

  39. Wang K, Bao L, Xiong W, Ma K, Han J, Wang W, Yin W, Liu H. Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase. J Nat Prod. 2015;78(8):1977-89.

  40. Zhao ZZ, Yin RH, Chen HP, Feng T, Li ZH, Dong ZJ, Cui BK, Liu JK. Two new triterpenoids from fruiting bodies of fungus Ganoderma lucidum. J Asian Nat Prod. 2015;17(7):750-5.

  41. Wang XF, Yan YM, Wang XL, Ma XJ, Fu XY, Cheng YX. Two new compounds from Ganoderma lucidum. J Asian Nat Prod Res. 2015;17(4):329-32.

  42. Zhao ZZ., Chen HP, Dong ZJ, Liu JK, Feng T, Li ZH. Lucidimine A-D, four new alkaloids from the fruiting bodies of Ganoderma lucidum. J Asian Nat Prod. 2015;17(12):1160-65.

  43. Fraga I, Coutinho J, Bezerra RM, Dias AA, Marques G, Nunes FM. Influence of culture medium growth variables on Ganoderma lucidum exopolysaccharides structural features. Carbohydr Polym. 2014;111:936-46.

  44. Sudheer S, Yeoh WK, Manickam S, Ali A. Effect of ozone gas as an elicitor to enhance the bioactive compounds in Ganoderma lucidum. Postharvest Biol Technol. 2016;117:81-88.

  45. Yang J, Chen YW, Leong NI, Zhao J, Duan, JA, Tang YP, Li SP. Quality evaluation of different products derived from Ganoderma. J. Med. Plant Res. 2012;6(10):1969-74.

  46. Torres-Torres MG, Guzmán-Dávalos L, De Mello Gugliotta A. Ganoderma in Brazil: Known Species and New Records. Micotaxon. 2012;121(40):93-132.

  47. García-Bustos MF, González-Prieto G, Ramos F, Mora MC, Hashiguchi Y, Parodi C, et al. Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases. Act Trop. 2016;154:125-32.

  48. Bar-Or D, Bar-Or R, Rael LT, Brody EN. Oxidative stress in severe acute illness. Redox Biol. 2015;4:340-45.

  49. Guzmán M, Santafé G, Torres O, Angulo A. Chemical study and antioxidant and Bactericide activities from Ganoderma applanatum. Rev Bio Agro. 2013;11(1):88-93.

  50. Christie W. Mass Spectrometry of Fatty Acid Derivatives. The AOCS Lipid Library [citado 22 ago 2014]; 2009. Disponible en: http://lipidlibrary.aocs.org/ms/masspec.html.

  51. Niedermeyer T, Lindequist U, Mentel R, Gordes D, Schmidt E, Thurow K, Lalk M. Antiviral Terpenoid Constituents of Ganoderma pfeifferi. J Nat Prod. 2005;68:1728-31.

  52. Fukuzawa M. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull. 2008;31:1933-37.

  53. Gao P. Isolation and identification of C-19 fatty acids with anti-tumor activity from the spores of Ganoderma lucidum (reishi mushroom). Fitoterapia. 2012;83:490-99.

  54. Zhang J, Zheng L, Magnusson K, Wang J, Liu X. Lipid extract from completely sporoderm-broken germinating Ganoderma sinensis spores elicits potent antitumor immune responses in human macrophages. Phytotherapy Research. 2009;23(6):844-50.

  55. Lv GP, Zhao J, Duan JA, Tang, YP, Li SP. Comparison of sterols and fatty acids in two species of Ganoderma. Chem Cent J. 2012;6(1):10-18.

  56. Zhen H, Zhang Z, Chen H, Tian Z. Antioxidant activity of ethanol extract from Ganoderma lucidum cultivated in the medium supplemented with herbs. AJMP. 2013;1(1):006-013.

  57. Sánchez E, Santafé G, Torres O, Robledo S. Compuestos sintéticos del tipo estirilquinolinas con actividades leishmanicida y citotóxica. Biomédica. 2014;34:605-611.

  58. No JH. Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries. Acta Trop. 2016;155:113-23




2020     |     www.medigraphic.com